I disagree. If any BP, or even SAVA, announced similar results to Anavex's controlled PDD trial, coupled with the results of their controlled Rett trial, their corresponding MC would be $3B-$5B higher.
The SP did ramp up to $32 on the tremendous news. So, did the market say "oh wait, we made a mistake; we better sell"?